Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03538171
What this trial is testing

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer
Taizhou EOC Pharma Co., Ltd. 375
Early research (Phase 1)UnknownNCT04756934
What this trial is testing

HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Who this might be right for
Melanoma
Taizhou HoudeAoke Biomedical Co., Ltd. 63
Testing effectiveness (Phase 2)UnknownNCT05007938
What this trial is testing

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT03051906
What this trial is testing

Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Azienda Ospedaliero-Universitaria Careggi 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07135804
What this trial is testing

Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Squamous Cell Carcinoma
Second Affiliated Hospital of Nanchang University 45
Early research (Phase 1)Looking for participantsNCT07660432
What this trial is testing

SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Ended earlyNCT04971187
What this trial is testing

Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT02723253
What this trial is testing

Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 18
Large-scale testing (Phase 3)Study completedNCT00110019
What this trial is testing

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IIIA Skin Melanoma+3 more
National Cancer Institute (NCI) 823
Large-scale testing (Phase 3)UnknownNCT02854072
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Samsung Pharmaceutical Co., Ltd. 148
Early research (Phase 1)Looking for participantsNCT07364357
What this trial is testing

A Phase I Study of CREPT-618 in Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05574101
What this trial is testing

Radiation Therapy and Cemiplimab for People With Skin Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin CancerSquamous Cell Carcinoma+4 more
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT02723877
What this trial is testing

PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)

Who this might be right for
Metastatic Breast Cancer
PIQUR Therapeutics AG 41
Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90
Early research (Phase 1)Active Not RecruitingNCT05160545
What this trial is testing

GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT02437656
What this trial is testing

Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Centre Oscar Lambret 60
Testing effectiveness (Phase 2)UnknownNCT06308939
What this trial is testing

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

Who this might be right for
Metastatic Breast Cancer
Zhejiang Cancer Hospital 81
Large-scale testing (Phase 3)Looking for participantsNCT06452277
What this trial is testing

Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer 555
Not applicableStudy completedNCT04667312
What this trial is testing

Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
AstraZeneca 115
Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11
Next Page